IMCR: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Cash Flow Overview

No enough data to generate the overview

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Total revenue	295,538	-
Cost of revenue from sale of therapies	2,384	-
PRAMEPrograms	59,950	-
Tebentafusp Programs	30,196	-
Infectious Disease Programs	4,077	-
Other Clinical And Pre Clinical Costs	42,035	-
R&d expenses-External RD	136,258	-
R&d expenses-Salaries And Other Employee Related Cost	35,882	-
Sg&a expenses-Salaries And Other Employee Related Cost	39,083	-
Sg&a expenses-Other Selling General And Administrative Expenses	60,992	-
Other segment (expense) income, net	26,393	-
Net loss	-5,454	-5,277
Share-based compensation expense	29,359	19,522
Depreciation	2,432	1,634
Unrealized foreign exchange gains, net	10,229	607
Unrealized gains on marketable securities	15,224	10,162
Non-cash lease expense	1,681	1,114
Other	-1,576	-1,049
Increase in accounts receivable	9,330	3,341
Increase in prepayments and other current assets	5,724	-365
(decrease) increase in accounts payable	-3,874	-3,587
Increase in accrued expenses	37,920	22,787
Decrease in deferred revenue	-243	-97
Increase (decrease) in operating lease liabilities	524	-528
Increase in other operating assets	1,471	-3,527
Increase in other operating liabilities	0	0
Net cash provided by operating activities	21,943	26,399
Purchase of marketable securities	30,000	30,000
Proceeds from sale of marketable securities	16,000	10,000
Purchase of property and equipment	1,460	712
Net cash used in investing activities	-15,460	-20,712
Proceeds from exercise of share options	8,087	6,221
Proceeds from issue of convertible senior notes	0	0
Payments for debt issuance costs	0	0
Net cash provided by financing activities	8,087	6,221
Increase in cash and cash equivalents	14,570	11,908
Effect of exchange rate changes on cash	28,112	-
Cash and cash equivalents at beginning of period	455,731	-
Cash and cash equivalents at end of period	498,413	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

IMCR: the cashflow